Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biocells (Beijing) Biotechnology is a specialized Chinese life sciences company focused on the development and manufacturing of high-quality cell culture media and related reagents. The company provides essential raw materials for the production of vaccines, recombinant proteins, and monoclonal antibodies, catering to both academic research and industrial bioprocessing. Biocells operates large-scale manufacturing facilities that adhere to international quality standards, ensuring the consistency and performance of their serum-free and chemically defined media products. By supporting the upstream processing needs of the biopharmaceutical industry, the company plays a critical role in the domestic and international supply chain for biologics manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biocells (Beijing) Biotechnology.